159351-69-6, Anti Cancer Drug of EVEROLIMUS (RAD001)

Basic Info

Model No.: 159351-69-6

Additional Info

Packaging: AS REQUIRED

Productivity: G,KGS,

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: COMMERCIAL PRODUCTION

Certificate: GMP/ISO

Product Description

We are offering in wide range of Pharmaceutical Intermediates CAS159351-69-6, Anti Cancer Drug of EVEROLIMUS (RAD001). These high quality products are formulated by adopting quality methods and using well-tested ingredients that are procured from the certified vendors of the market. We offer these products in proper packaging of diverse quantity to meet assorted requirements of the clients.

• Thera. Category:Anti-Cancer
• Cas No.:159351-69-6
• Synonym:42-O-(2-Hydroxyethyl)-rapamycin;Certica;RAD-001;SDZRAD;Rapamycin, 42-O-(2-hydroxyethyl)-;Everolimus;Certican;CERTICAN(R)
• Molecular Formula:C53H83NO14

• 
  
• Molecular Weight:958.232
• Specifications:Available on request
• Packing:Export worthy packing
• Material Safety Data Sheet:Available on request

Usage: Treats advanced kidney cancer. Also treats some types of pancreatic cancer, breast cancer, and brain cancer. Used with other medicines to keep your body from rejecting a transplanted kidney or liver.

A derivative of the macrolide Rapamycin (Cat. No. 1568-5, 50) that acts as an immunosuppressant, mTOR inhibitor and anticancer agent. It targets the raptor mammalian target of rapamycin (mTORC1).